AvKARE recalls

AvKARE is recalling one lot of fludrocortisone acetate 0.1 mg tablets because testing found impurity or degradation levels above required limits. The recall covers lot 48353 (expiration 10/31/2026) in 50-tablet unit-dose cartons, NDC 50268-330-15, distributed nationwide. No injuries have been reported.

Moderate·FDA·Oct 30, 2026

AvKARE is recalling one lot of amitriptyline hydrochloride 10 mg tablets because they failed dissolution specifications. The recall covers 3,534 cartons of 50-count unit dose cards distributed nationwide. No injuries have been reported.

Moderate·FDA·Oct 28, 2026

AvKARE is recalling one lot of Amantadine HCl 100 mg capsules because they failed to meet dissolution specifications—meaning the capsules may not break down properly in the body, affecting how much medicine you receive. This is a quality issue identified during manufacturing testing. No injuries have been reported.

Moderate·FDA·Mar 4, 2026

AvKARE is recalling Rosuvastatin 10 mg tablets (Lot #49124, expiring 12/31/2026) because they don't dissolve properly in the body. This means the medication may not work as intended. No injuries have been reported so far.

Moderate·FDA·Jan 14, 2026